Mercy Health is committed to medical research and clinical trials for patients suffering from leukemia, lymphoma and other blood cancers. From bone marrow transplants to trials for patients with polycythemia vera, see our listing of ongoing clinical trials and medical studies below to see if you’d be a possible candidate for participation.

Bone Marrow Transplant

Myelodysplastic Syndrome (MDS)
Older Adult MDS Allo (50-75 Years old)
Study Number: BMT CTN 1102
Protocol Title: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome
Status: Open
Principal Investigator: James Essell, M.D.
To learn more, please call The Jewish Hospital — Mercy Health Cincinnati Cancer and Cellular Therapy Center at 513-686-5482.


Multiple Myeloma 
Surveillance, Contact, and Research for MGUS, Myeloma, and Amyloidosis
Study Number: NCT01408225
Principal Investigator: Rex Mowat, MD
Please call 419-251-4919 to learn more.

If you believe that you would be a strong candidate for one of our blood cancer clinical trials, please reach out to the contacts listed above. Participating in medical trials gives you access to new or emerging treatment options that are not yet widely available, and allows you to help push medical research forward in the process.

Why Choose Mercy Health?
Mercy Health physicians and healthcare professionals are conducting medical research to help patients live healthier and longer. They are committed to making lives better—mind, body and spirit.